These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2313341)

  • 1. MOPP dose intensity and survival: flawed analysis.
    Cohen MH
    J Clin Oncol; 1990 Apr; 8(4):756-7. PubMed ID: 2313341
    [No Abstract]   [Full Text] [Related]  

  • 2. MOPP after two decades.
    Rosenberg SA
    J Clin Oncol; 1986 Sep; 4(9):1289-90. PubMed ID: 3755754
    [No Abstract]   [Full Text] [Related]  

  • 3. [MOPP therapy of Hodgkin's disease previously treated with MOPP].
    Frau A; Montalar J
    Med Clin (Barc); 1985 May; 84(19):801. PubMed ID: 3839875
    [No Abstract]   [Full Text] [Related]  

  • 4. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
    Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
    [No Abstract]   [Full Text] [Related]  

  • 5. MOPP after two decades.
    Longo DL; Young RC; Duffey PL; Hubbard SM; DeVita VT
    J Clin Oncol; 1987 Feb; 5(2):320-1. PubMed ID: 3806177
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
    Longo DL; Duffey PL; DeVita VT; Wiernik PH; Hubbard SM; Phares JC; Bastian AW; Jaffe ES; Young RC
    J Clin Oncol; 1991 Aug; 9(8):1409-20. PubMed ID: 1712836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients.
    Gobbi PG; Cavalli C; Rossi A; Bertoloni D; Galeone F; Pieresca C; Grignani E
    Haematologica; 1987; 72(6):523-8. PubMed ID: 3126109
    [No Abstract]   [Full Text] [Related]  

  • 8. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
    Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
    Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hodgkin's lymphoma in children: results of treatment with the MOPP protocol and a combination of radiotherapy and chemotherapy].
    Vuković I; Janković MB; Janić D; Stojimirović E
    Srp Arh Celok Lek; 1985; 113(11-12):1013-21. PubMed ID: 3841764
    [No Abstract]   [Full Text] [Related]  

  • 12. ABVD versus MOPP: which is better?
    Rosenberg SA
    J Clin Oncol; 1987 Jan; 5(1):7. PubMed ID: 2433410
    [No Abstract]   [Full Text] [Related]  

  • 13. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract]   [Full Text] [Related]  

  • 14. Is anything better than MOPP?
    Longo DL
    Hematol Oncol; 1993; 11(2):65-71. PubMed ID: 8406376
    [No Abstract]   [Full Text] [Related]  

  • 15. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP
    Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hodgkin's disease in children; treatment results with or without radiotherapy].
    van Bunningen BN; Dewit L; Bartelink H
    Ned Tijdschr Geneeskd; 1986 May; 130(20):928-9. PubMed ID: 3755223
    [No Abstract]   [Full Text] [Related]  

  • 17. MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians.
    Andrieu JM; Yilmaz U; Colonna P
    J Clin Oncol; 1999 Feb; 17(2):730-4. PubMed ID: 10080622
    [No Abstract]   [Full Text] [Related]  

  • 18. [Improved survival rates in Hodgkin's disease].
    Hayabuchi N; Jingu K; Miyoshi M; Hirata H; Masuda K; Shibuya T; Nishimura J; Komiyama S; Ishii E; Kikuchi M
    Gan No Rinsho; 1988 Apr; 34(5):698-704. PubMed ID: 2455073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
    Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
    J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.